Research Fellowship (MSc) – Immunogenicity of rAAV Oeiras

Research Fellowship (MSc) – Immunogenicity of rAAV
Oeiras
Oeiras, Distrito de Lisboa, Portugal

Research Fellowship (MSc) – Immunogenicity of r
AAV

Instituto de Biologia Experimental e Tecnológica (i
BET), Oeiras, Portugal, has an open position for a research fellowship in the field of Biomedical Sciences available within the project “Immunopredict – Immune cell assays for prediction of immunogenicity of recombinant Adeno-associated virus (r
AAV)”, financed by internal funds.

Education

BSc in Biology, Biotechnology, Biological Engineering, or equivalent scientific areas. Average classification of BSc of at least 15 values.

Other Requirements

• Preference will be given to candidates with previous experience in animal cell culture, namely mammalian cell lines, primary myeloid and/or lymphoid cells;
• Experience in the following topics will be considered a plus:
  • Flow cytometry;
  • Fluorescence Microscopy;
  • Analytical methods (e. g. , q
    PCR, ELISA, Western blot);
  • Molecular biology methods (e. g. , enzymatic restriction, cloning);
  • Relevant software for data analysis and visualization (e. g. , Graph
    Pad Prism, Image
    J, Flow
    Jo, R Studio);
• Results-oriented, motivated,
  - driven, and a team player;
• Good spoken and written English expression;
• Immediate availability.

The project aims to develop and implement in vitro assays using mononucleated cells from peripheral blood (myeloid and/or lymphoid lineage), to study the immunogenicity of biological therapeutic agents. We will develop in vitro assays using cells selected from peripheral blood mononucleated cells from buffy coats (e. g. T cells, monocytes), with the aim of studying the response of immune system cells to viral vectors (r
AAVs) for gene therapy. Particularly, we will study the activation of
- derived dendritic cells and consequent activation of T cells, after stimulation with viral vectors with different characteristics to predict their immunogenicity and understand the immunogenic response to new therapeutic modalities.

The fellowship will have a duration of 6 months, eventually renewed until the end of the project, without prejudice to the maximum limits foreseen by law. The expected starting date is 15 of September of 2024.

Apply now with your detailed CV, motivation letter, and degree certificates to jobs@ibet. pt, referring to the job reference in the subject of the email (Immunopredict_Agust_24)